EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis

Fuji Yang, Yanshuang Wu, Yifei Chen, Jianbo Xi, Ying Chu, Jianhua Jin, Yongmin Yan

JHEP Reports · 2023-07 · 5 (7) · 100746

DOI: 10.1016/j.jhepr.2023.100746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JHEP Reports, 2023-07. Verfasst von Fuji Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, China. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, National Natural Science Foundation of China, Jiangsu Provincial Commission of Health and Family Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) affects nearly a quarter of the population with no approved pharmacological therapy. Liver steatosis is a primary characteristic of NAFLD. Recent studies suggest that human umbilical cord mesenchymal stem cell-derived exosomes (MSC-ex) may provide a promising strategy for treating liver injury; however, the role and underlying mechanisms of MSC-ex in steatosis are not fully understood.

Methods

Oleic-palmitic acid-treated hepatic cells and high-fat diet (HFD)-induced NAFLD mice were established to observe the effect of MSC-ex. Using non-targeted lipidomics and transcriptome analyses, we analysed the gene pathways positively correlated with MSC-ex. Mass spectrometry and gene knockdown/overexpression analyses were performed to evaluate the effect of calcium/calmodulin-dependent protein kinase 1 (CAMKK1) transferred by MSC-ex on lipid homoeostasis regulation.

Results

Here, we demonstrate that MSC-ex promote fatty acid oxidation and reduce lipogenesis in oleic-palmitic acid-treated hepatic cells and HFD-induced NAFLD mice. Non-targeted lipidomics and transcriptome analyses suggested that the effect of MSC-ex on lipid accumulation positively correlated with the phosphorylation of AMP-activated protein kinase. Furthermore, mass spectrometry and gene knockdown/overexpression analyses revealed that MSC-ex-transferred CAMKK1 is responsible for ameliorating lipid accumulation in an AMP-activated protein kinase-dependent manner, which subsequently inhibits SREBP-1C-mediated fatty acid synthesis and enhances peroxisome proliferator-activated receptor alpha (PPARα)-mediated fatty acid oxidation.

Conclusions

MSC-ex may prevent HFD-induced NAFLD via CAMKK1-mediated lipid homoeostasis regulation. Impact and Implications: NAFLD includes many conditions, from simple steatosis to non-alcoholic steatohepatitis, which can lead to fibrosis, cirrhosis, and even hepatocellular carcinoma. So far, there is no approved drug for treating liver steatosis of NAFLD. Thus, better therapies are needed to regulate lipid metabolism and prevent the progression from liver steatosis to chronic liver disease. By using a combination of non-targeted lipidomic and transcriptome analyses, we revealed that human umbilical cord mesenchymal stem cell-derived exosomes (MSC-ex) effectively reduced lipid deposition and improved liver function from HFD-induced liver steatosis. Our study highlights the importance of exosomal CAMKK1 from MSC-ex in mediating lipid metabolism regulation via AMPK-mediated PPARα/CPT-1A and SREBP-1C/fatty acid synthase signalling in hepatocytes. These findings are significant in elucidating novel mechanisms related to MSC-ex-based therapies for preventing NAFLD.

Schlagwörter

Stichwörter der Autor:innen

AMPKCAMKK1ExosomesMSCNAFLDSteatosis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Wujin Hospital Affiliated with Jiangsu University, Jiangsu University, Changzhou, China.
  • School of Medicine, Jiangsu University, Zhenjiang, China.
  • Department of Laboratory Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Changzhou Key Laboratory of Molecular Diagnostics and Precision Cancer Medicine, Wujin Hospital Affiliated with Jiangsu University (Wujin Clinical College of Xuzhou Medical University), Changzhou, China.

Förderung

  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy
  • National Natural Science Foundation of China
  • Jiangsu Provincial Commission of Health and Family Planning
  • Jiangsu Provincial Key Research and Development Program
  • Jiangsu Commission of Health

Zitieren

APA

Yang, F., Wu, Y., Chen, Y., Xi, J., Chu, Y., Jin, J., & Yan, Y. (2023). Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis. JHEP Reports, 5(7), 100746. https://doi.org/10.1016/j.jhepr.2023.100746

Vancouver

Yang F, Wu Y, Chen Y, Xi J, Chu Y, Jin J, et al. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis. JHEP Reports. 2023;5(7):100746. doi:10.1016/j.jhepr.2023.100746

BibTeX
@article{Yang2023,
  author = {Yang, Fuji and Wu, Yanshuang and Chen, Yifei and Xi, Jianbo and Chu, Ying and Jin, Jianhua and Yan, Yongmin},
  title = {Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis},
  journal = {JHEP Reports},
  year = {2023},
  volume = {5},
  number = {7},
  pages = {100746},
  doi = {10.1016/j.jhepr.2023.100746}
}
Kostenlos starten →